DiagnaMed Holdings Corp. · CSE:DMED

DiagnaMed — Investor Presentation (2023)

12 slides from DiagnaMed's investor presentation, 2023

  1. Slide 1: Generative AI Brain Health Solutions

    Generative AI Corporate Presentation Brain Health Solutions Q4-2023 DiagnaMed Holdings Corp. 82 Richmond Street East Toronto, ON M5C 1P1 e. info@diagnamed.com t. 416-800-2684

  2. Slide 2: Our Focus

    Our Focus Commercializing Digital Brain Health Solutions using Generative AI

  3. Slide 3: Digital Brain Health Market

    +1 Billion Digital Brain Mental Health Depression, PTSD, Anxiety, etc Health Market over $375 Billion +1 Billon by 2031* Neurodegenerative Parkinson's, Alzheimer's, Brain injury, Dementia, *Source: TMR Report https://www.prnewswire.com/news-releases/digital-brain-health-market-to-exceed- value-of-us

  4. Slide 4: Problem

    Problem I have a family There is no one-fits-all solution for history of Alzheimer's estimating, monitoring and I'm feeling depressed I keep on improving brain health. forgetting things ----- Expensive equipment and unproven intervention methods. ----- Require a reliable and scalable solution.

  5. Slide 5: Our Solution

    Our Solution CERVAI™ Brain Health Platform Estimating Brain Age Validation studies performed Providing Brain Health Risk Score Monitoring overall Brain Health Implementing support solutions Utilizing in clinic and home

  6. Slide 6: CERVAI Features

    CERVAI™ Features Brain Age Brain Health Estimation Risk Score Use of novel Evaluate overall brain electroencephalogram health, output a patient (EEG) device and ML/AI risk score, and provide techniques for predicting actionable data. and monitoring brain age. Brain Health CERVAI™ Brain Health Brain

  7. Slide 7: CERVAI Journey

    CERVAI™ Journey 1 How is my brain health? 2 3 1 2 3 TAKING CONTROL ESTIMATING BRAIN AGE BRAIN HEALTH ASSESSMENT Schedule a visit to a CERVAI™ Place a safe and easy to use EEG Take an online brain health provider if curious or concerned headset for EEG collection assessment about your brain health 4

  8. Slide 8: Business Model

    Business Model License Fees Place in up to 25,000 provider locations in North America (Primary care physicians, psychiatric & neurology clinics, senior care homes, pharmacies, sport teams) Recurring Visits Programs offered up to 4 visits per year App Subscriptions Monthly subscription to virtual cli

  9. Slide 9: Commercial Pathway

    Commercial Pathway 2024 H2-2023 H2-2023 Unlock new uses of CERVAI™ Commercialize Clinical diagnostic tool for CERVAI™ monitoring and screening of mental health, neurological and Grow provider sites, consumer brain injuries Establish CERVAI™ provider and patient awareness network Licensed physicians

  10. Slide 10: Partnerships

    Partnerships Brain Age Brain Health CERVAI Solution Solution Development Team

  11. Slide 11: Team

    Team Management Advisors Fabio Chianelli Dr. John Kounios, PhD Founder, Chairman, and CEO Principal Researcher - Brain AGE Founder, CEO - PharmaTher Applied Cognitive & Brain Sciences Founder, President - Revive Thera Professor, Drexel University Jing Peng, CPA Dr. James E Galvin, M.D., M.P.H. Chief

  12. Slide 12: Capital Structure

    80,052,640 ~ 21% Capital Common Shares outstanding Insider Ownership Structure 2,000,000 Stock Options 240,000 Warrants $0.10 expires June 18, 2023 37,382,226 Common Shares are subject to escrow 1/10th released at: November 8, 2023, 2024, 2025 May 8, 2024, 2025, 2026 2/10th released at: November 8,

DiagnaMed Holdings — Investor Presentation (2023) on 6ix